Overview


According to FutureWise analysis the market for Oncology Information System in 2023 is US$ 2.7 billion, and is expected to reach US$ 5.05 billion by 2031 at a CAGR of 8.10%.

Oncology information system (OIS) is used to manage the data of cancer patient treatment programmes, treatments plans, treatment deliveries, treatment summaries and diagnostic results. The OIS will encircle the information exchange with other departments within the health care enterprise and it must be connected to other hospitals information system. It will assist in the evaluation and improvement of therapy from information on cancer stage and treatment. OIS accredits improved medical safety and professional effectiveness. There are various resources like paper-based (hospital registries), network etc., which will help to maintain oncology information at healthcare enterprise.

The increasing demand for IT services due to increasing prevalence is expected to fuel the growth of oncology information systems market. It is advantageous over traditional methods of data handling validations and it further decreased the manual effort and automated the process. Along with this, the oncology information system has huge applicability in healthcare settings for better management of cancer patients. Further, changing healthcare policies to encourage smart technologies led to robust growth of oncology information systems market. Additionally, it improves patient care and helps in better management of cancer patients. All these factors led to significant growth of burgeoning growth of oncology information systems market.

Global Oncology information system market is dominated by North America and Europe due to high penetration and well-established healthcare systems. Further, they are expected to remain dominant throughout the forecast period. The Asia Pacific is expected to create a lot of opportunities for manufacturers due to the high patient population. Latin America and Rest of World Oncology information systems market are expected to witness slow growth over the forecast period due to slow adoption.Oncology Information Systems market is expected to witness new players during the forecast period due to the increasing importance of information systems in data management.

  • Accuray Incorporated
  • Bogardus Medical Systems, Inc.
  • Cerner Corporation
  • CureMD Corporation
  • Elekta AB
  • Flatiron Health, Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • RaySearch Laboratories AB
  • Varian Medical Systems, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Application

  • Surgical Oncology
  • Radiation Oncology
  • Medical Oncology

By Products and Services

  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Professional Services
    • Consulting/Optimization Services
    • Implementation Services
    • Post-sale and Maintenance Services

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Centres
  • Clinics

By Region

  • Europe
  • North America
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on Global Oncology Information System Market By Application, Products and Services Type, End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Oncology Information System Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Oncology Information System Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Oncology Information System Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Oncology Information System Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Oncology Information System Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Surgical Oncology
        2. Radiation Oncology
        3. Medical Oncology

  • 8.   Global Oncology Information System Market, By Products and Services Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Software
         1.1. Patient Information Systems
         1.2. Treatment Planning Systems
        2. Professional Services
         2.1. Consulting/Optimization Services
         2.2. Implementation Services
         2.3. Post-sale and Maintenance Services

  • 9.   Global Oncology Information System Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Outpatient Centres
        4. Clinics

  • 10.   North America Oncology Information System Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.   Latin America Oncology Information System Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.   Europe Oncology Information System Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.   Asia Pacific Oncology Information System Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.   Middle East and Africa Oncology Information System Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Accuray Incorporated
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bogardus Medical Systems, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cerner Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. CureMD Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Elekta AB
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Flatiron Health, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Koninklijke Philips N.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. McKesson Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. RaySearch Laboratories AB
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Varian Medical Systems, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients